What is Daiichinkyo Co Price-to-Operating-Cash-Flow?
As of today (2024-12-13), Daiichinkyo Co's share price is 円4449.00.
Daiichinkyo Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2024 was 円305.98. Hence, Daiichinkyo Co's Price-to-Operating-Cash-Flow Ratio for today is 14.54.
The historical rank and industry rank for Daiichinkyo Co's Price-to-Operating-Cash-Flow or its related term are showing as below:
TSE:4568'
s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 7.79 Med: 24.72 Max: 1958.55
Current: 14.83
During the past 13 years, Daiichinkyo Co's highest Price-to-Operating-Cash-Flow Ratio was 1958.55. The lowest was 7.79. And the median was 24.72.
Daiichinkyo Co's Cash Flow from Operations per share for the
three
months ended in Sep. 2024 was 円17.53.
Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2024 was 円305.98.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Daiichinkyo Co was 14477.20% per year.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 46.70% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 24.10% per year.
During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 14.40% per year.
During the past 13 years, Daiichinkyo Co's highest 3-Year average Operating Cash Flow per Share Growth Rate was 56.40% per year. The lowest was -35.80% per year. And the median was 5.90% per year.
Daiichinkyo Co Price-to-Operating-Cash-Flow Historical Data
The historical data trend for Daiichinkyo Co's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Daiichinkyo Co Price-to-Operating-Cash-Flow Chart
|
Daiichinkyo Co Annual Data
|
|
Trend |
Mar15 |
Mar16 |
Mar17 |
Mar18 |
Mar19 |
Mar20 |
Mar21 |
Mar22 |
Mar23 |
Mar24 |
| Price-to-Operating-Cash-Flow |
|
Get a 7-Day Free Trial
|
|
|
24.55 |
32.58 |
36.93 |
80.79 |
15.24 |
|
Daiichinkyo Co Quarterly Data
|
|
Dec19 |
Mar20 |
Jun20 |
Sep20 |
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
Jun22 |
Sep22 |
Dec22 |
Mar23 |
Jun23 |
Sep23 |
Dec23 |
Mar24 |
Jun24 |
Sep24 |
| Price-to-Operating-Cash-Flow |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
|
|
|
|
1,956.17 |
12.35 |
15.24 |
19.80 |
15.39 |
Competitive Comparison of Daiichinkyo Co's Price-to-Operating-Cash-Flow
For the Drug Manufacturers - General subindustry, Daiichinkyo Co's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Daiichinkyo Co's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Daiichinkyo Co's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Daiichinkyo Co's Price-to-Operating-Cash-Flow falls into.
Daiichinkyo Co Price-to-Operating-Cash-Flow Calculation
Daiichinkyo Co's Price-to-Operating-Cash-Flow ratio for today is calculated as
| Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
| = | 4449.00 | / | 305.975 |
| = | 14.54 |
Daiichinkyo Co's Share Price of today is 円4449.00.
Daiichinkyo Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円305.98.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
Daiichinkyo Co Business Description
Traded in Other Exchanges
Address
3-5-1, Nihonbashi-honcho, Chuo-ku, Tokyo, JPN, 103-8426
Daiichi Sankyo was established by the merger of Daiichi Pharmaceuticals and Sankyo in 2005. As of 2023, approximately one third of revenue comes from its Japan businesses, which will shrink in the future as the company expands its global footprint. Its primary growth driver is its leading platform of antibody drug conjugates, or ADCs. Its three lead ADCs are Enhertu (HER2), Dato-DXd (TROP2), I-DXd (B7-H3), HER3-DXd (HER3), and R-DXd (CDH6). Enhertu entered the clinic in 2015 and received its first US approval in December 2019 for third-line late-stage HER2-positive breast cancer. It is also approved for HER2-positive stomach cancers and HER2 mutant non-small cell lung cancer.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TSE:4568 has been successfully added to your